Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
October 23–26, 2024
The German company Constellr is part of the John Deere Start-Up Collaborator Program in 2024. It plans to launch a geothermal satellite next year that will give farmers and ranchers better tools to monitor surface temperature from space.
In an interview with RFD-TV’s own Suzanne Alexander, RanchHER Pilar Martinez talked about the upcoming RanchHER episodes on the way, including one that features her operation, Centennial Ranch in Dillion, Montana.

LATEST STORIES BY THIS AUTHOR:

The U.S. government will give pharmaceutical company Moderna $176 million for a High-Path Avian Flu vaccine, Reuters reports.
RFD-TV Agricultural Law & Taxation expert Roger McEowen discusses the Supreme Court’s recent repeal of the Chevron agreement and other current topics in ag law.
With today’s post, RFD-TV Ag Legal & Tax Expert Roger McEowen focuses on some more common issues farmers, ranchers, and rural landowners frequently face.